Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1107

1.

Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.

Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR.

Gastroenterology. 2007 Sep;133(3):790-8. Epub 2007 Jul 3.

PMID:
17854591
2.

Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.

Goldstein JL, Howard KB, Walton SM, McLaughlin TP, Kruzikas DT.

Clin Gastroenterol Hepatol. 2006 Nov;4(11):1337-45.

PMID:
17088110
3.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.

Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.

4.
5.

Underutilization of preventive strategies in patients receiving NSAIDs.

Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.

Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii23-31.

6.

Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.

Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.

Aliment Pharmacol Ther. 2004 Nov 15;20(10):1091-7.

7.

Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.

Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.

J Rheumatol. 2002 Mar;29(3):467-73.

PMID:
11908558
8.

Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons.

Smalley WE, Ray WA, Daugherty JR, Griffin MR.

Am J Epidemiol. 1995 Mar 15;141(6):539-45.

PMID:
7900721
9.

Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs.

Smalley W, Stein CM, Arbogast PG, Eisen G, Ray WA, Griffin M.

Arthritis Rheum. 2002 Aug;46(8):2195-200.

10.

Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.

Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.

Am J Med. 2005 Nov;118(11):1271-8.

PMID:
16271912
11.

The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.

Pilotto A, Franceschi M, Leandro G, Paris F, Niro V, Longo MG, D'Ambrosio LP, Andriulli A, Di Mario F.

Aging Clin Exp Res. 2003 Dec;15(6):494-9.

PMID:
14959953
12.

The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.

Targownik LE, Metge CJ, Leung S, Chateau DG.

Gastroenterology. 2008 Apr;134(4):937-44. doi: 10.1053/j.gastro.2008.01.010. Epub 2008 Jan 11.

PMID:
18294634
13.
14.

Comparing rates of dyspepsia with Coxibs vs NSAID+PPI: a meta-analysis.

Spiegel BM, Farid M, Dulai GS, Gralnek IM, Kanwal F.

Am J Med. 2006 May;119(5):448.e27-36.

PMID:
16651060
15.
16.

COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.

van der Linden MW, Gaugris S, Kuipers EJ, van Herk-Sukel MP, van den Bemt BJ, Sen SS, Herings RM.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):880-90. doi: 10.1002/pds.1782.

PMID:
19593747
18.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

19.

Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals.

Greenberg JD, Bingham CO 3rd, Abramson SB, Reed G, Kishimoto M, Hinkle K, Kremer J.

Arthritis Rheum. 2006 Aug 15;55(4):543-50.

20.

Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.

Naesdal J, Wilson I.

Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1401-6. Review.

PMID:
11742186
Items per page

Supplemental Content

Write to the Help Desk